These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6488876)

  • 1. Phase I treatment of women with metastatic breast cancer with baboon anti-gross cystic disease fluid protein.
    Estabrook A; Kister SJ; Hardy MA; Grossbard L; Oster MW; Davis S; Mazoujian G; Haagenson DE
    Curr Surg; 1984; 41(5):375-8. PubMed ID: 6488876
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-human primate (baboon) anti-gross cystic disease fluid protein-15 antibody infusion in four women with metastatic breast carcinoma.
    Estabrook A; Kister SJ; Hardy MA; Grossbard L; Oster MW; Davis S; Mazoujian G; Haagensen DE
    Cancer Immunol Immunother; 1986; 23(2):143-7. PubMed ID: 3490912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
    Wallace ML; Longacre TA; Smoller BR
    Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gross cystic disease fluid protein (GCDFP-15) in the breast: past and present.
    Sapino A; Cassoni P; Bussolati G
    J Biol Regul Homeost Agents; 2000; 14(4):259-62. PubMed ID: 11215813
    [No Abstract]   [Full Text] [Related]  

  • 5. Androgen stimulation of gross cystic disease fluid protein and carcinoembryonic antigen in patients with metastatic breast carcinoma.
    Dilley WG; Leight GS; Silva JS; Ammirata S; Haagensen DE; Wells SA
    J Natl Cancer Inst; 1983 Jan; 70(1):69-74. PubMed ID: 6571924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic breast carcinoma presenting as endometrial cancer. A case report.
    Lallas TA; Taskin M; Calanog A; Shevchuk MM
    J Reprod Med; 1997 Feb; 42(2):121-3. PubMed ID: 9058349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of 19th year pulmonary metastasis after radical mastectomy for breast cancer].
    Dohba S; Kondoh M; Fujita H; Kinami S; Inoue T; Komura Y; Ii T; Takegawa S; Kiriyama M; Kojima Y; Kibe Y; Watanabe K
    Kyobu Geka; 2000 Dec; 53(13):1129-32. PubMed ID: 11127561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation.
    Manni A; Santen RJ; Boucher AE; Lipton A; Harvey H; Drago J; Rohner T; Haagensen D; Glode M; Santner SJ
    Anticancer Res; 1984; 4(3):141-4. PubMed ID: 6380398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ultrastructural localization of gross cystic disease fluid protein (GCDFP-15) in breast epithelium.
    Mazoujian G; Warhol MJ; Haagensen DE
    Am J Pathol; 1984 Aug; 116(2):305-10. PubMed ID: 6205595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen in breast cancer.
    Anand A
    Hosp Pract (Off Ed); 1993 Jun; 28(6):17. PubMed ID: 8509477
    [No Abstract]   [Full Text] [Related]  

  • 11. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
    Lee BH; Hecht JL; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma.
    Kapadia SB; Barnes L
    Mod Pathol; 1998 Nov; 11(11):1033-8. PubMed ID: 9831198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women.
    Petrakis NL; Barnes S; King EB; Lowenstein J; Wiencke J; Lee MM; Miike R; Kirk M; Coward L
    Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):785-94. PubMed ID: 8896889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer metastatic to the eyelids.
    Claessens N; Rakic L; Arrese JE; Pierard GE
    Eur J Dermatol; 2000 Aug; 10(6):473-4. PubMed ID: 10980473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
    Raju U; Ma CK; Shaw A
    Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor markers for breast carcinoma.
    Haagensen DE
    Clin Lab Med; 1982 Sep; 2(3):543-65. PubMed ID: 6754225
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
    Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
    Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach.
    Caputo E; Camarca A; Moharram R; Tornatore P; Thatcher B; Guardiola J; Martin BM
    Biochemistry; 2003 May; 42(20):6169-78. PubMed ID: 12755619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor associated markers in breast cancer.
    Franchimont P; Zangerle PF; Colin C; Osterrieth P; Hendrick JC; van Cauwenberge JR; Hustin J
    Eur J Cancer (1965); 1980; Suppl 1():17-20. PubMed ID: 6172278
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of the major protein components in breast secretions from women with benign and malignant breast diseases.
    Sánchez LM; Vizoso F; Díez-Itza I; López-Otín C
    Cancer Res; 1992 Jan; 52(1):95-100. PubMed ID: 1727390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.